Finance

Beta
Lists
099430:KOSDAQ
Bio Plus Co Ltd
â‚©4,075.00
-4.23%
(-180.00) 1D
Jul 2, 3:30:24 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 099430...
Open
â‚©4,160
High
â‚©4,240
Low
â‚©4,005
Mkt. cap
251.19B
Avg. vol.
496.92K
Volume
471.36K
Dividend
1.72%
Quarterly dividend
â‚©17
Ex-dividend date
Dec 27, 2024
P/E ratio
31.00
52-wk high
â‚©8,350
52-wk low
â‚©3,785
EPS
â‚©131
Shares outstanding
61.64M
No. of employees
145
Open
â‚©4,160
High
â‚©4,240
Low
â‚©4,005
Mkt. cap
251.19B
Avg. vol.
496.92K
Volume
471.36K
Dividend
1.72%
Quarterly dividend
â‚©17
Ex-dividend date
Dec 27, 2024
P/E ratio
31.00
52-wk high
â‚©8,350
52-wk low
â‚©3,785
EPS
â‚©131
Shares outstanding
61.64M
No. of employees
145
News stories
From sources across the web
About Bio Plus Co Ltd
CEOHyun Kyu Jung
Employees145
Founded2003
Headquarters-
SectorMedical device
Websitebioplus.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.67B
24.06B
23.18B
26.51B
Cost of goods sold
7.65B
6.52B
8.32B
8.37B
Cost of revenue
7.65B
6.52B
8.32B
8.37B
Research and development expenses
764.32M
800.51M
958.40M
870.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.49B
9.72B
10.27B
10.33B
Operating expense
10.91B
12.66B
13.91B
12.49B
Total operating expenses
18.56B
19.18B
22.24B
20.85B
Operating income
2.12B
4.88B
947.62M
5.65B
Other non operating income
3.32B
49.56M
-1.08B
278.22M
EBT including unusual items
4.19B
5.53B
402.04M
7.22B
EBT excluding unusual items
4.04B
5.49B
397.31M
6.69B
Income tax expense
764.09M
1.12B
-3.24B
-775.92M
Effective tax rate
18.23%
20.30%
-805.10%
-10.74%
Other operating expenses
59.73M
436.96M
48.25M
253.36M
Net income
2.18B
3.12B
2.00B
6.69B
Net profit margin
10.56%
12.97%
8.64%
25.23%
Earnings per share
-
-
-
-
Interest and investment income
145.36M
51.68M
186.85M
158.68M
Interest expense
-80.27M
-72.70M
-82.57M
-74.73M
Net interest expenses
65.09M
-21.02M
104.27M
83.95M
Depreciation and amortization charges
540.24M
521.51M
204.13M
461.92M
EBITDA
3.33B
6.03B
1.83B
6.86B
Gain or loss from assets sale
-
-9.00K
35.54M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer